USPTO Patent Grants - Pharma (A61K)

Lipid Triglyceride Surfactant Composition, Patent US12599580B2

The USPTO granted patent US12599580B2 to BASF AS on April 14, 2026, covering compositions comprising 2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenyloxy)butanoic acid, a triglyceride, and a surfactant, as well as methods of using the same in self-emulsifying drug delivery systems such as SEDDS, SMEDDS, or SNEDDS. The patent contains 20 claims.

Enzyme-Cleavable Prodrug Compositions and Controlled Release Nafamostat Methods

USPTO granted patent US12599578B2 to Ensysce Biosciences Inc. for pharmaceutical compositions including enzyme-cleavable prodrugs providing enzymatically-controlled release of active agents, combined with controlled release nafamostat. The patent covers 12 claims and methods of use for these pharmaceutical compositions.

Axcess Global Sciences LLC Patent - Ketone Bodies and Amino Acid Compositions

The USPTO granted patent US12599579B2 to Axcess Global Sciences LLC covering compositions of ketone bodies or ketone body precursors complexed with amino acids. The patent, effective April 14, 2026, contains 22 claims and names Gary Millet, Ryan Lowery, Jacob Wilson, and Terry Lacore as inventors. The compositions are directed toward uses including weight loss, blood glucose management, muscle performance, metabolic repair, neurological treatment, and anti-aging applications.

Nanoparticle Wound Healing Treatment Patent US12599698B2

USPTO granted patent US12599698B2 to Kismet Technologies Inc. on April 14, 2026, covering a therapeutic article with metal-modified cerium oxide nanoparticles (mCNPs) for wound healing and antimicrobial infection control. The patent includes 19 claims for the nanoparticle-treated fiber composition with particles sized 3-35nm.